title: [Clinical characteristics and treatment of polyneuropathy developed after chemotherapy].
abstract: Chemotherapy-induced peripheral neuropathy (CIPN) is one of the main problem of modern cytotoxic therapy. Drug dose reduction, delay or even complete stopping of chemotherapy until the regression of CIPN symptoms impair treatment effectiveness and patients' survival. We studied 44 cancer patients with CIPN developed after polychemotherapy. We suggested a treatment regimen that included a complex of allopathic, homeopathic drugs and hydrotherapy. The treatment resulted in a subjective and objective regression of neuropathy symptoms and improving of quality of life in all patients. Patients who had to delay chemotherapy were able to restart it.
authors.forename: N B
authors.initials: NB
authors.lastname: Kholodova
authors.forename: V M
authors.initials: VM
authors.lastname: Sotnikov
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Dobrovol'skaia
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Ponkratova
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006705:Homeopathy / Q000379:methods*; D006801:Humans; D006875:Hydrotherapy / Q000379:methods*; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D020258:Neurotoxicity Syndromes / Q000209:etiology / Q000628:therapy*; D011115:Polyneuropathies / Q000139:chemically induced / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents